 CORAL GABLES, Fla., Sept. 3, 2021 PRNewswire -- Relmada Therapeutics, Inc. NASDAQ: RLMD, a late-stage biotechnology company addressing diseases of the central nervous system CNS, today announced that Sergio Traversa, Chief Executive Officer of Relmada, will present at the 19th Annual Morgan Stanley Global Healthcare Conference, on September 10, 2021, at 12:30 pm Eastern Time. 